Recent development of gold(<scp>i</scp>) and gold(<scp>iii</scp>) complexes as therapeutic agents for cancer diseases-Reference-Cited by-同舟云学术

Recent development of gold(i) and gold(iii) complexes as therapeutic agents for cancer diseases

Published:2022 Issue:13 Volume:51 Page:5518-5556
ISSN:0306-0012
Container-title:Chemical Society Reviews
language:en
Short-container-title:Chem. Soc. Rev.

Author:

Lu Yunlong¹^ORCID,Ma Xiaoyan¹,Chang Xingyu¹,Liang Zhenlin¹,Lv Lin¹,Shan Min¹,Lu Qiuyue¹,Wen Zhenfan¹,Gust Ronald²^ORCID,Liu Wukun¹³^ORCID

Affiliation:

1. Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China

2. Institute of Pharmacy/Pharmaceutical Chemistry, University of Innsbruck, Center for Chemistry and Biomedicine, Innsbruck, Austria

3. State key Laboratory of Coordination Chemistry, Nanjing University, Nanjing, 210023, China

Abstract

In this review, the recent progress in gold(i) and gold(iii) complexes are comprehensively summarized, and their anti-cancer activity and mechanism of action are documented.

Funder

National Natural Science Foundation of China

Nanjing University of Chinese Medicine

Priority Academic Program Development of Jiangsu Higher Education Institutions

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2022/CS/D1CS00933H

Reference265 articles.

1. Targeting and delivery of platinum-based anticancer drugs